The US senator says that diabetes and weight loss drugs have changed their life, the reason

The U.S. senator said he changed the life of a GLP-1 medicine and now called on the anti-obesity drugs.

On April 8, in Op-ed in the New York Times, Sent. John Fetterman, D-Pa., Written about the experience with Mounjaro (Tirzepatide).

Enjjecable recipe medication is primarily used to treat type 2 diabetes.

Ozempic’s health benefits continue to grow, but are the risks worth it?

Fetterman appointed medicine in July 2025.

“As be saved from the shotI was interested in the work showing (Mounjaro) (MoNJaro) can significantly reduce the risk of large heart events, “the senator wrote.

“I’m starting to pick me up hearts of heartsI hit me for how well I felt on the board. This has significantly affected the general health, “he said.

“Aches, pains and stiffness disappeared. Physically, I feel more clearly and more optimistic and more optimistic. I lost 20 pounds for side effects.”

Genetic cholesterol was eliminated by new drugs, reduces the risk of heart attack, finds learning

Outside the reduction of blood sugar, GLP-1 medicines, Fox News are also associated with infotal health, neurological function and metabolic function and metabolic function and metabolic health and metabolic health and metabolic health.

Eli Lilly, Mounjaro also offers another version of the drug called Zepbound, which is the same drug, which is approved for chronic weight management. Sleep apnea.

Other GLP-1 medications were developed by Özepik, Wegovy, Vickoza, Saxen, all new Nordisk.

Fetterman noted that GLP-1 drugs were found to have a useful impact on cholesterol, heart rate and heart inflammation.

“Some recent studies can help even curve alcohol addiction and support the cognitive function that canceled or prevented the terms of the terms and conditions like Parkinson and Alzheimer’s. “

“Physically, I feel more clear and more optimistic for years.”

OP-ED, Fetterman called the expanded entry These drugsIn the absence of insurance, which is worth $ 1000, which is cost from pocket.

“Currently, Medicare covers these medications only in special conditions such as diabetes or grown heart risk,” he said. “And Medicaid coverage is even limited.”

Fetterman added that he was not compensated to share his experience.

Ozempic ‘mikodosan’ is a new weight loss trend

“I am only a man who benefits from these drugs and benefit from them and want to be sure of them,” he said.

When sharing Fetterman Hhs sec. Robert F. Kennedy Jr. said that the priority and healthy living views of the feeding and healthy living, he believed that drugs are necessary for some of the drugs.

“I fully agree with the diet and the diet and Lifestyle – Lots. But only the diet is not enough, “he said.

“Medicines for millions of Americans fighting serious health problems may be an important first step to restore enough control over their health to start meaningful lifestyle changes.”

Doctors discuss benefits and access

Dr. MARC Siegel, New Langone Health and Fox News ‘in Clinical Medicine Prof.’ Semaglutides, including Chief Medical Analytics, Ozempic and Wegovy, noted that “very important drugs” 2 Write diabeteswith increased use for obesity.

“Despite the useful uses for the heart and lipid profile of these drugs – also the risk of brain and dementia continues to decrease and need more information,” said Fox News digital.

First Approach to fat Siegel said, including lifestyle changes, exters, improved diet and optimal sleep.

“He said that this weight loss drugs (including zepbound) are good vehicles in the absence of lifestyle.”

“They help prevent diseases low as heart disease, stroke, high pressure and sleep apnea.

He added that “We generally save the healthcare system, so Medicare and Medicaid would like to confirm them for diabetes and losing weight loss“

Click here to sign up for our health newsletter

Dr. Brett Osborn, Florida Neurologist and Longevity Specialist, said he has set GLP-1S to patients since 2019.

“Mounjaro and his uncle’s son are not only weight loss tools – they are not metabolic reset buttons,” said Fox News digital.

“People with metabolic syndrome do not need the importance of kale and exercise. They need their help.”

Osborn acknowledged the way of lifestyles, but “rarely enough.”

“GLP-1S, rounding the ball, they are accelerating to patients,” he said. “And when this happened, health habits are formed. The diet is better. The movement is improving. They begin to feel the benefits of healthy living.”

Visit for more health articles www.foxnews.com/setich

Osborn noted that these drugs are not cosmetics, not therapeutic.

“I saw what I could do in advance: significantly reduced in body fat, inflammation, glucose, triglycerides and insulin resistance and a significant reduction in insulin resistance.”

“I believe this is a flawless signal in Big Pharma.”

President Donald Trump’s leadership recently announced that Medicare and Medicaid will not cover medicines, because Medicare and Medicaid services were told Friday for centers.

Osborn said that it has prevented the action to block the fact that it is necessary not to be affected.

“Trump knows the work of these drugs,” said Osborn. “I believe this is a hurricane signal in Big Pharma: ‘The price or medicare is the largest buyer in the block, the largest buyer.”

Click here to get FOX News app

“It’s not free from work – it said, Osborn.

“President Trump is likely to negotiate the price,” the price is right, “he will negotiate the Great Pharma while the Americans deny the health.”